Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/93049
Title: Activity-based proteome profiling of potential cellular targets of orlistat - An FDA-approved drug with anti-tumor activities
Authors: Yang, P.-Y.
Liu, K.
Ngai, M.H. 
Lear, M.J. 
Wenk, M.R.
Yao, S.Q. 
Issue Date: 20-Jan-2010
Citation: Yang, P.-Y., Liu, K., Ngai, M.H., Lear, M.J., Wenk, M.R., Yao, S.Q. (2010-01-20). Activity-based proteome profiling of potential cellular targets of orlistat - An FDA-approved drug with anti-tumor activities. Journal of the American Chemical Society 132 (2) : 656-666. ScholarBank@NUS Repository.
Abstract: Orlistat, or tetrahydrolipstatin (THL), is an FDA-approved antiobesity drug with potential antitumor activities. Cellular off-targets and potential side effects of Orlistat in cancer therapies, however, have not been extensively explored thus far. In this study, we report the total of synthesis of THL-like protein-reactive probes, in which extremely conservative modifications (i.e., an alkyne handle) were introduced in the parental THL structure to maintain the native biological properties of Orlistat, while providing the necessary functionality for target identification via the bio-orthogonal click chemistry. With these natural productlike, cell-permeable probes, we were able to demonstrate, for the first time, this chemical proteomic approach is suitable for the identification of previously unknown cellular targets of Orlistat. In addition to the expected fatty acid synthase (FAS), we identified a total of eight new targets, some of which were further validated by experiments including Western blotting, recombinant protein expression, and site-directed mutagenesis. Our findings have important implications in the consideration of Orlistat as a potential anticancer drug at its early stages of development for cancer therapy. Our strategy should be broadly useful for off-target identification against quite a number of existing drugs and/or candidates, which are also covalent modifiers of their biological targets. © 2010 American Chemical Society.
Source Title: Journal of the American Chemical Society
URI: http://scholarbank.nus.edu.sg/handle/10635/93049
ISSN: 00027863
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

127
checked on Mar 8, 2018

WEB OF SCIENCETM
Citations

132
checked on Dec 31, 2018

Page view(s)

101
checked on Aug 2, 2020

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.